27697474|t|Formation of an Intraretinal Fluid Barrier in Cavitary Optic Disc Maculopathy
27697474|a|Cavitary optic disc maculopathy develops when fluctuating pressure gradients along anomalous communications in the optic nerve head induce migration of fluid into the adjacent retinal tissue. We sought to determine whether carefully titrated laser photocoagulation combined with vitrectomy and gas tamponade can safely create an effective intraretinal barrier to fluid egress from the optic disc cavitation. Retrospective interventional case series. We retrospectively evaluated medical records and imaging studies of 22 consecutive patients with cavitary disc maculopathy evaluated by a single surgeon between 1991 and 2014. Patients requiring surgery underwent carefully titrated juxtapapillary laser photocoagulation followed immediately by vitrectomy and gas tamponade. Main outcome measures were change in visual acuity, macular fluid resolution, and recurrence of maculopathy. Eleven patients (11 eyes) had undergone vitreous surgery and were included in the study. No preoperative evidence for vitreous traction on the optic disc or macula was seen in any eye. Nine patients underwent a single surgery and 2 patients required additional procedures to resolve the macular fluid. Mean length of follow-up after the last surgery was 48.2 months (range, 4-143 months). All 11 patients (100%) had complete resolution of macular fluid, with an average time to resolution of 8.5 months (range, 1-18 months). Only 1 of 11 patients (9%) had recurrence of macular fluid (14 months postoperatively). The average preoperative visual acuity of 20/125 (logMAR 0.81, standard deviation [SD] = 0.36) improved by nearly 4 lines to an average final visual acuity of 20/57 (logMAR 0.45, SD = 0.37) (P = .0072). A possible laser - induced central scotoma was suspected in only 1 patient who had undergone extensive prior laser treatments. An effective intraretinal barrier to fluid migration from cavitary optic disc anomalies can be safely achieved in most patients with carefully titrated juxtapapillary laser photocoagulation combined with vitrectomy and gas tamponade. Once achieved, the barrier facilitates resolution of macular fluid and long-term avoidance of recurrent maculopathy.
27697474	0	9	Formation	T169	C1522492
27697474	16	28	Intraretinal	T029	C0005898
27697474	29	42	Fluid Barrier	T033	C4062768
27697474	46	65	Cavitary Optic Disc	T023	C0029127
27697474	66	77	Maculopathy	T047	C0730362
27697474	78	97	Cavitary optic disc	T023	C0029127
27697474	98	109	maculopathy	T047	C0730362
27697474	124	135	fluctuating	T079	C0231241
27697474	136	144	pressure	T067	C0033095
27697474	145	154	gradients	T081	C0812409
27697474	161	170	anomalous	T033	C3277934
27697474	193	209	optic nerve head	T023	C0029127
27697474	217	226	migration	T169	C0232902
27697474	230	235	fluid	T031	C0005889
27697474	245	253	adjacent	T082	C0205117
27697474	254	261	retinal	T023	C0035298
27697474	262	268	tissue	T024	C0040300
27697474	283	292	determine	T080	C0521095
27697474	311	319	titrated	T058	C1883350
27697474	320	342	laser photocoagulation	T061	C0441510
27697474	357	367	vitrectomy	T061	C0042903
27697474	372	385	gas tamponade	T061	C1960208
27697474	407	416	effective	T080	C1704419
27697474	417	429	intraretinal	T029	C0005898
27697474	430	453	barrier to fluid egress	T033	C4062768
27697474	463	473	optic disc	T023	C0029127
27697474	486	499	Retrospective	T080	C1514923
27697474	531	546	retrospectively	T080	C1514923
27697474	557	572	medical records	T170	C0025102
27697474	577	592	imaging studies	T060	C1881134
27697474	599	610	consecutive	T080	C1707491
27697474	611	619	patients	T101	C0030705
27697474	625	638	cavitary disc	T023	C0029127
27697474	639	650	maculopathy	T047	C0730362
27697474	651	660	evaluated	T058	C0220825
27697474	666	672	single	T081	C0205171
27697474	673	680	surgeon	T097	C0582175
27697474	704	712	Patients	T101	C0030705
27697474	723	730	surgery	T169	C0038895
27697474	751	759	titrated	T058	C1883350
27697474	760	774	juxtapapillary	T023	C0229962
27697474	775	797	laser photocoagulation	T061	C0441510
27697474	807	818	immediately	T079	C0205548
27697474	822	832	vitrectomy	T061	C0042903
27697474	837	850	gas tamponade	T061	C1960208
27697474	857	864	outcome	T080	C0085415
27697474	865	873	measures	T081	C0079809
27697474	879	885	change	T169	C0392747
27697474	889	902	visual acuity	T201	C0042812
27697474	904	917	macular fluid	T031	C0005889
27697474	918	928	resolution	T169	C0205245
27697474	934	944	recurrence	T067	C0034897
27697474	948	959	maculopathy	T047	C0730362
27697474	968	976	patients	T101	C0030705
27697474	981	985	eyes	T023	C0015392
27697474	1001	1017	vitreous surgery	T061	C2037746
27697474	1043	1048	study	T062	C2603343
27697474	1050	1074	No preoperative evidence	T080	C0332125
27697474	1079	1096	vitreous traction	T047	C3161192
27697474	1104	1114	optic disc	T023	C0029127
27697474	1118	1124	macula	T023	C0450295
27697474	1141	1144	eye	T023	C0015392
27697474	1151	1159	patients	T101	C0030705
27697474	1179	1186	surgery	T061	C0543467
27697474	1193	1201	patients	T101	C0030705
27697474	1211	1221	additional	T169	C1524062
27697474	1222	1232	procedures	T169	C2700391
27697474	1236	1243	resolve	T169	C0205245
27697474	1248	1261	macular fluid	T031	C0005889
27697474	1263	1267	Mean	T081	C0444504
27697474	1268	1287	length of follow-up	UnknownType	C0814872
27697474	1303	1310	surgery	T061	C0543467
27697474	1320	1326	months	T079	C0439231
27697474	1328	1333	range	T081	C1514721
27697474	1341	1347	months	T079	C0439231
27697474	1357	1365	patients	T101	C0030705
27697474	1386	1396	resolution	T169	C0205245
27697474	1400	1413	macular fluid	T031	C0005889
27697474	1423	1430	average	T081	C1510992
27697474	1439	1449	resolution	T169	C0205245
27697474	1457	1463	months	T079	C0439231
27697474	1465	1470	range	T081	C1514721
27697474	1477	1483	months	T079	C0439231
27697474	1499	1507	patients	T101	C0030705
27697474	1517	1527	recurrence	T067	C0034897
27697474	1531	1544	macular fluid	T031	C0005889
27697474	1549	1555	months	T079	C0439231
27697474	1556	1571	postoperatively	T079	C0032790
27697474	1578	1585	average	T081	C1510992
27697474	1586	1598	preoperative	T079	C0445204
27697474	1599	1612	visual acuity	T201	C0042812
27697474	1637	1655	standard deviation	T081	C0871420
27697474	1657	1659	SD	T081	C0871420
27697474	1702	1709	average	T081	C1510992
27697474	1716	1729	visual acuity	T201	C0042812
27697474	1753	1755	SD	T081	C0871420
27697474	1788	1793	laser	T061	C0850168
27697474	1796	1803	induced	T169	C0205263
27697474	1804	1819	central scotoma	T033	C0152191
27697474	1844	1851	patient	T101	C0030705
27697474	1870	1879	extensive	T080	C0205231
27697474	1880	1885	prior	T079	C0332152
27697474	1886	1902	laser treatments	T061	C0850168
27697474	1907	1916	effective	T080	C1280519
27697474	1917	1929	intraretinal	T029	C0005898
27697474	1930	1946	barrier to fluid	T033	C4062768
27697474	1947	1956	migration	T169	C0232902
27697474	1962	1991	cavitary optic disc anomalies	T047	C1969063
27697474	2023	2031	patients	T101	C0030705
27697474	2047	2055	titrated	T058	C1883350
27697474	2056	2070	juxtapapillary	T023	C0229962
27697474	2071	2093	laser photocoagulation	T061	C0441510
27697474	2108	2118	vitrectomy	T061	C0042903
27697474	2123	2136	gas tamponade	T061	C1960208
27697474	2157	2164	barrier	T033	C4062768
27697474	2177	2187	resolution	T169	C0205245
27697474	2191	2204	macular fluid	T031	C0005889
27697474	2209	2218	long-term	T079	C0443252
27697474	2232	2241	recurrent	T079	C2945760
27697474	2242	2253	maculopathy	T047	C0730362